<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31864">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02018718</url>
  </required_header>
  <id_info>
    <org_study_id>UF 9097</org_study_id>
    <nct_id>NCT02018718</nct_id>
  </id_info>
  <brief_title>Development and Validation Phase of Diffusion Tensor Imaging and Arterial Spin Labelling at 3 Tesla Using a Long-term Effort Model Applicable to Skeletal Muscle Characterization.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to demonstrate and quantify the micro architecture and micro
      vascular changes within skeletal muscles after marathon using 3T MRI (diffusion tensor and
      arterial spin labeling). Apparent diffusion coefficient, fractional anisotropy and flow
      parameters will be registered before and after the long-distance run on the lower leg. Axial
      T1 and axial SPAIR sequences will also be applied at the same time.Stress ox and
      inflammatory markers will be collected in blood and urine samples and compare with both MRI
      and Near-infrared spectroscopy (NIRS).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Fractional Anisotropy (FA) measure</measure>
    <time_frame>at 4 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The measures will be made from sequences echoplanar (EAR), and will be extracted by post-treatment software Siemens untitled &quot; Syngo&quot; and &quot;FSL&quot;, allowing a distortions correction.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Apparent Diffusion Coefficient (ADC) value</measure>
    <time_frame>at 4 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Marathoners.</condition>
  <condition>Men Between 25 and 50 Years Old.</condition>
  <arm_group>
    <arm_group_label>Marathoners</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic Resonance Imaging (MRI)</intervention_name>
    <arm_group_label>Marathoners</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Realizing between 2:10 and 4:30 in the marathon.

        Exclusion Criteria:

          -  Smoker

          -  Subject with medical treatment or with a treatment interrupted for less than 30 days.

          -  Subject with a osteo-articular, cardiovascular, infectious, lung pathology and/or a
             metabolic chronic pathology.

          -  MRI Contraindication : Claustrophobic subject ; subject with a intra-cranial vascular
             clip, with a pacemaker, with a neurostimulator or a cochlear implant ; subject with
             intraocular metallic foreign bodies.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sébastien BOMMART</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sébastien BOMMART</last_name>
    <phone>+334 67 33 60 00</phone>
    <email>s-bommart@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Montpellier</name>
      <address>
        <city>Montpellier Cedex 5</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sébastien BOMMART</last_name>
      <phone>+334 67 33 60 00</phone>
      <email>s-bommart@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Sébastien BOMMART</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 20, 2013</lastchanged_date>
  <firstreceived_date>December 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Skeletal muscle</keyword>
  <keyword>Marathon</keyword>
  <keyword>MRI</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
